Immune therapy targets cells that cause leukemia relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.

‘Measures and Meaning’ exhibition features AAP alums, faculty

Opening June 6, the exhibition curated by the College of Architecture, Art and Planning features work by 20 alumni and faculty as part of ongoing celebrations of the Department of Architecture's 150th year and a century of art education at Cornell.

Nostril swab best way to test for COVID-19, study finds

Nasopharyngeal swabs – taken from far back inside the nostril – were found to be more effective at detecting COVID-19 than saliva tests or swabs just inside the nostril or under the tongue.

Tear down academic silos: Take an ‘undisciplinary’ approach

Solving problems like climate change could require dismantling rigid academic boundaries, so that researchers of various backgrounds may collaborate through an “undisciplinary” approach.

Cornellian-founded company implants 3D-bioprinted ear

In a first-of-its-kind clinical trial, a human has received a 3D-bioprinted ear implant grown from the patient’s own living cells – thanks to a technology platform developed by a Cornellian-founded startup company.

Higher dengue rates found near public transit in low-income areas

In Medellin, Colombia, low-income residents who lived in close proximity to new public transit stations had increased rates of mosquito-transmitted dengue fever, according to a new study.

Discovery offers starting point for better gene-editing tools

In new research, Cornell scientists define with atomic precision how a transposon-derived system edits DNA in RNA-guided fashion. 

Instrument-building festival challenges, inspires

The FutureSounds Festival extended the existing sound world with presentations by guest builders and performers and newly designed instruments and compositions by Cornell students.

Study reveals potential therapies for aggressive lymphoma

The Weill Cornell Medicine research takes a step toward precision medicine for a type of cancer that disproportionately affects people with African ancestry, an underserved population.